X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
34.59%
↑ 228% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
-27.10%
Historical baseline
PeriodValue
202534.59%
2024-35.63%
2023-25.17%
2022-8.74%
2021-20.55%
2020-22.40%
2019-17.49%
2018-46.76%
2017-28.80%
2016-100.06%